Form 4: Camp4 Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Andrew J. Schwab, a Director of Camp4 Therapeutics Corp, received 3,179,558 shares of common stock on August 3, 2026.
Summary
- Grant/award: acquired 3,179,558 Pre-Funded Warrant (Right to Buy) at $1.53 ($4,864,406) on August 3, 2026; holds 3,179,558 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Andrew J. Schwab — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-03 | Grant/award | Pre-Funded Warrant (Right to Buy) | 3,179,558 | $2 | $4.9M | 3,179,558 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-03 | Grant/award (3,179,558 shares) |
Keywords
insider transaction, Form 4, CAMP, Camp4 Therapeutics Corp, neutral, Andrew J. Schwab
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.